Transamerica Financial Advisors buys $1,600,535 stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Transamerica Financial Advisors scooped up 2,652 additional shares in Colgate-Palmolive Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 23,176 shares of Colgate-Palmolive Company which is valued at $1,600,535.Colgate-Palmolive Company makes up approximately 0.14% of Transamerica Financial Advisors’s portfolio.

Colgate-Palmolive Company opened for trading at $69.11 and hit $69.74 on the upside on Wednesday, eventually ending the session at $69.31, with a gain of 0.51% or 0.35 points. The heightened volatility saw the trading volume jump to 44,70,872 shares. Company has a market cap of $61,876 M.

Other Hedge Funds, Including , Wendell David Associates Inc reduced its stake in CL by selling 5,164 shares or 2.24% in the most recent quarter. The Hedge Fund company now holds 225,761 shares of CL which is valued at $15,591,055. Colgate-Palmolive Company makes up approx 3.00% of Wendell David Associates Inc’s portfolio. Vontobel Asset Management Inc sold out all of its stake in CL during the most recent quarter. The investment firm sold 193,500 shares of CL which is valued $13,363,110.Manning Napier Advisors reduced its stake in CL by selling 4,608 shares or 3.5% in the most recent quarter. The Hedge Fund company now holds 127,237 shares of CL which is valued at $9,065,636. Colgate-Palmolive Company makes up approx 0.06% of Manning Napier Advisors’s portfolio.Eqis Capital Management boosted its stake in CL in the latest quarter, The investment management firm added 1,276 additional shares and now holds a total of 13,381 shares of Colgate-Palmolive Company which is valued at $949,248. Colgate-Palmolive Company makes up approx 0.07% of Eqis Capital Management’s portfolio.

On the company’s financial health, Colgate-Palmolive Company reported $0.73 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 29, 2016. Analyst had a consensus of $0.72. The company had revenue of $3899.00 million for the quarter, compared to analysts expectations of $3927.05 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Downgraded by Sterne Agee CRT to ” Neutral” on Feb 26, 2016. Shares were Reiterated by UBS on Feb 1, 2016 to “Neutral” and Lowered the Price Target to $ 67 from a previous price target of $69 .

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.